MedTrace Logo

Bilateral Percutaneous Nephrolithomy

NCT03924362 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2022-05-17

No results posted yet for this study

Summary

The purpose of this study is to determine the effective regimen for definitive surgical therapy of bilateral kidney stones. It is unknown whether patients who undergo simultaneous bilateral percutaneous nephrolithotomy (PCNL) experience improved post-operative outcomes compared to patients who have staged unilateral procedures.

Conditions

  • Nephrolithiasis of Both Kidneys

Interventions

PROCEDURE

PCNL

Percutaneous Nephrolithotomy is a means of treating large kidney stone burdens.

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Ben Chew, MD · University of British Columbia, Associate Professor

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-30
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03924362 on ClinicalTrials.gov